Conjugates

TW202629248APending Publication Date: 2026-07-16DAWN THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114139114
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-09
Filing Date
2025-10-09
Publication Date
2026-07-16
Patent Text Reader

Abstract

The invention relates to conjugates, specifically conjugates capable of crossing the blood-brain barrier. Provided herein is a conjugate comprising a therapeutic and / or imaging moiety, a targeting moiety, a spacer and a lipid. Also provided herein is an intermediate conjugate further comprising a reactive moiety, and linker reagents. Pharmaceutical compositions, uses, methods of medical treatment and prophylaxis, methods of delivering a functional moiety, and compositions are also disclosed herein.
Need to check novelty before this filing date? Find Prior Art